2026-04-07 – Press Releases – www.prnewswire.com
MELBOURNE, Australia and INDIANAPOLIS, April 7, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) provides a market update on its commercial and operational performance for the quarter ended March 31, 2026 (Q1 2026). Q1 2026 Highlights Q1 2026 unaudited…
